Transforming and Optimizing Legal Operations With Digital Transaction Management
May 02, 2016 09:00 ET
|
ThinkSmart, LLC
SAN FRANCISCO, CA--(Marketwired - May 02, 2016) - ThinkSmart, a leader in Digital Transaction Management, will showcase its Automation Platform (TAP), with extensive Legal Operation features, at...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016
February 05, 2016 12:42 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Automating Legal Operations to Achieve Transparency and Compliance
February 02, 2016 08:00 ET
|
ThinkSmart, LLC
SAN FRANCISCO, CA--(Marketwired - February 02, 2016) -
ThinkSmart, a leader in Digital Transaction Management, will showcase its Transaction Automation Platform (TAP), with extensive Legal...
Otonomy Presents AuriPro(TM) Phase 3 Results at American Society of Pediatric Otolaryngology Conference
April 27, 2015 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, April 27, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
ADEA Scholarship Provides Faculty With Leadership Skills for Advancement
March 19, 2013 16:01 ET
|
American Dental Education Association
SEATTLE, March 19, 2013 (GLOBE NEWSWIRE) -- During the Opening Session of the 2013 ADEA Annual Session & Exhibition on March 17, the American Dental Education Association (ADEA) named Pamella P. Shaw,...
FDA Accepts Complete Response Submission Regarding the Ampligen(R) New Drug Application for Chronic Fatigue Syndrome
August 14, 2012 08:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Aug. 14, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) (the "Company" or "Hemispherx") filed on July 31, 2012 with the U.S. Food and Drug Administration its complete...
Hemispherx Biopharma Announces Filing a New Drug Application in Argentina for Ampligen(R) to Treat Chronic Fatigue Syndrome
July 18, 2012 08:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, July 18, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) (the "Company" or "Hemispherx"), announced that it has submitted a new drug application to ANMAT (Administracion...
Hemispherx Biopharma and the FDA Reach Agreement on Filing Requirements for the Company's Complete Response in Support of Ampligen(R) New Drug Application for Chronic Fatigue Syndrome Treatment
July 11, 2012 08:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, July 11, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) (the "Company" or "Hemispherx") recently met with representatives of the U.S. Food and Drug Administration (the...
Elite Pharmaceuticals Signs an Agreement With a Private Hong Kong-Based Company to Develop a Prescription Pharmaceutical Product in the US
March 22, 2012 16:15 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that it has entered into an agreement to develop for a...
Hemispherx Biopharma, Inc. to Host Conference Call on Chronic Fatigue Syndrome Progress Thursday, October 27, 2011
October 24, 2011 10:22 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Oct. 24, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex: HEB) (the "Company"), has scheduled a conference call and audio webcast on Thursday, October 27, 2011 at 2:00...